DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

被引：0
|
作者：
Christine Aaserød Pedersen
Maria Dung Cao
Thomas Fleischer
Morten B. Rye
Stian Knappskog
Hans Petter Eikesdal
Per Eystein Lønning
Jörg Tost
Vessela N. Kristensen
May-Britt Tessem
Guro F. Giskeødegård
Tone F. Bathen
机构：
[1] NTNU - Norwegian University of Science and Technology,Department of Circulation and Medical Imaging
[2] Østfold University College,Department of Nursing, Health and Laboratory Science
[3] Oslo University Hospital,Department of Cancer Genetics, Institute for Cancer Research
[4] Trondheim University Hospital,Clinic of Surgery, St. Olavs Hospital
[5] NTNU – Norwegian University of Science and Technology,Department of Clinical and Molecular Medicine
[6] Trondheim University Hospital,Clinic of Laboratory Medicine, St. Olavs Hospital
[7] NTNU – Norwegian University of Science and Technology,BioCore
[8] University of Bergen, Bioinformatics Core Facility
[9] Haukeland University Hospital,K.G. Jebsen Centre for Genome
[10] Université Paris Saclay,Directed Cancer Therapy, Department of Clinical Science
[11] Oslo University Hospital,Department of Oncology
[12] NTNU - Norwegian University of Science and Technology,Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humaine, CEA – Institut de Biologie François Jacob
[13] St. Olavs Hospital,Department of Medical Genetics, Institute of Clinical Medicine
[14] Trondheim University Hospital,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, and Nursing
来源：
Breast Cancer Research | / 24卷
关键词：
DNA methylation; Locally advanced breast cancer; Survival; Treatment response; Breast cancer; Neoadjuvant chemotherapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer
    Bolton, Nathan M.
    Maerz, Adam H.
    Brown, Russell E.
    Bansal, Mona
    Bolton, John S.
    Conway, William C.
    HPB, 2019, 21 (04) : 413 - 418
  • [22] Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy
    Lim, E. A.
    Gunther, J. E.
    Flexman, M.
    Kim, H. K.
    Hibshoosh, H.
    Kalinsky, K.
    Crew, K.
    Maurer, M.
    Taback, B.
    Feldman, S.
    Brown, M.
    Refice, S.
    Alvarez-Cid, M.
    Hielscher, A.
    Hershman, D. L.
    CANCER RESEARCH, 2012, 72
  • [23] A URINE-BASED DNA METHYLATION TEST TO MONITOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER
    Ghodoussipour, Saum
    Basin, Micheal F.
    Ahmadi, Hamed
    Seyedian, Seyedeh-Sanam Ladi
    Nusbaum, David J.
    Mitra, Anirban
    Piatti, Paolo
    Suwoto, Michiko
    Yamada, Taikun
    Gray, Matthew
    Jara, Benjamin
    Chew, Yap Ching
    Bhanvadia, Sumeet
    Djaladat, Hooman
    Schuckman, Anne
    Daneshmand, Siamak
    Liang, Gangning
    JOURNAL OF UROLOGY, 2020, 203 : E232 - E232
  • [24] The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
    Yildirim, Sedat
    Dogan, Akif
    Akdag, Goncagul
    Yasar, Zeynep Yuksel
    Bal, Hamit
    Kinikoglu, Oguzcan
    Oksuz, Sila
    Ozkerim, Ugur
    Tunbekici, Salih
    Yildiz, Hacer Sahika
    Alan, Ozkan
    Coban Kokten, Sermin
    Isik, Deniz
    Surmeli, Heves
    Basoglu, Tugba
    Sever, Ozlem Nuray
    Odabas, Hatice
    Yildirim, Mahmut Emre
    Turan, Nedim
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] Predictors of Response and Survival Outcomes of Triple Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
    Zhu, Meizhen
    Yu, Yang
    Shao, Xiying
    Zhu, Liang
    Wang, Linbo
    CHEMOTHERAPY, 2020, 65 (3-4) : 101 - 109
  • [26] Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
    Romero, A.
    Garcia-Saenz, J. A.
    Fuentes-Ferrer, M.
    Lopez Garcia-Asenjo, J. A.
    Furio, V.
    Roman, J. M.
    Moreno, A.
    de la Hoya, M.
    Diaz-Rubio, E.
    Martin, M.
    Caldes, T.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 655 - 661
  • [27] Insight or Confusion: Survival After Response-Guided Neoadjuvant Chemotherapy in Breast Cancer
    Telli, Melinda L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3613 - 3615
  • [28] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer
    Thomae, Keith
    Sargent
    Russell, Christy A.
    Russell
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 543 - 543
  • [29] Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival
    Precht, Lisa M.
    Lowe, Kimberly A.
    Atwood, Mary
    Beatty, J. David
    BREAST JOURNAL, 2010, 16 (04): : 362 - 368
  • [30] Neoadjuvant chemotherapy is not associated with improved survival for estrogen receptor positive/negative breast cancer
    Johnson, Jeffrey
    Barmparas, Galinos
    Chung, Alice
    Manguso, Nicholas
    Giuliano, Armando
    Amersi, Farin
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 138 - 139
12345